当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Sharath R
Cancer remains as one of the deadliest disease, causing large number of deaths worldwide. The expanding use of cancer immunotherapy has revealed that the survival patients suffer from various serious side effects due to the use of available anti-neoplastic medicines. The development of nanoparticle-based drugs seems to be effective providing low side effects and targeted action on cancer cells. The metal nanoparticles pose some side effects due to their toxicity whereas the Non-metallic Carbon dots (C-dots) are non –toxic and their applications in the field of medicine are less known. In the present study C-dots were synthesized by a simple single step wet chemical method from three different compounds namely Glucose (GCD), Sucrose (SCD) and Fructose (FCD) and characterized with UV-Visible and fluorescence spectroscopic techniques. The C-Dots were screened for the cytotoxicity against two cancer cell lines human Liver carcinoma cells (HepG2) and human breast carcinoma cells (MCF -7) by the MTT assay. The IC50 of the C-dot nanoparticles (SCD, GCD, FCD) on HepG2 cells were 67.24, <50 and and<50 μg/ml respectively and on MCF-7 cells were 105, <50 and <50 μg/ml respectively. The study reveals that the C-dots possess cytotoxic activity against the cancer cell lines and can be further used for the anticancer drug discovery.